MedPath

Picoplatin

Generic Name
Picoplatin
Drug Type
Small Molecule
Chemical Formula
C6H10Cl2N2Pt
CAS Number
181630-15-9
Unique Ingredient Identifier
B5TAN0L720

Overview

Picoplatin is a cytotoxic platinum compound in clinical development for the treatment of patients with solid tumors. It causes apoptosis (cell death) by binding to DNA and interfering with DNA replication and transcription.

Background

Picoplatin is a cytotoxic platinum compound in clinical development for the treatment of patients with solid tumors. It causes apoptosis (cell death) by binding to DNA and interfering with DNA replication and transcription.

Indication

For the treatment of patients with solid tumors.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1
Posted: 2008/07/04
Sponsor:
Poniard Pharmaceutic...
Phase 1
Completed
Posted: 2007/04/25
Sponsor:
Poniard Pharmaceutic...
Phase 3
Posted: 2007/04/25
Sponsor:
Poniard Pharmaceutic...
Phase 1
Posted: 2007/03/19
Sponsor:
Poniard Pharmaceutic...
Phase 2
Completed
Posted: 2005/06/30
Sponsor:
Poniard Pharmaceutic...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath